
### [NCIT:C8021](http://purl.obolibrary.org/obo/NCIT_C8021)
**Label:** Salivary Gland Adenocarcinoma

**Subclasses:** [NCIT:C5940](http://purl.obolibrary.org/obo/NCIT_C5940) (Submandibular Gland Adenocarcinoma), [NCIT:C5941](http://purl.obolibrary.org/obo/NCIT_C5941) (Parotid Gland Adenocarcinoma), [NCIT:C3678](http://purl.obolibrary.org/obo/NCIT_C3678) (Salivary Gland Basal Cell Adenocarcinoma), [NCIT:C5980](http://purl.obolibrary.org/obo/NCIT_C5980) (Salivary Gland Cystadenocarcinoma), [NCIT:C123384](http://purl.obolibrary.org/obo/NCIT_C123384) (Mammary Analog Secretory Carcinoma of Salivary Gland), [NCIT:C5958](http://purl.obolibrary.org/obo/NCIT_C5958) (Sublingual Gland Adenocarcinoma), [NCIT:C5903](http://purl.obolibrary.org/obo/NCIT_C5903) (Major Salivary Gland Adenocarcinoma), [NCIT:C62194](http://purl.obolibrary.org/obo/NCIT_C62194) (Salivary Gland Oncocytic Carcinoma), [NCIT:C5948](http://purl.obolibrary.org/obo/NCIT_C5948) (Minor Salivary Gland Adenocarcinoma), [NCIT:C5904](http://purl.obolibrary.org/obo/NCIT_C5904) (Salivary Duct Carcinoma), [NCIT:C62193](http://purl.obolibrary.org/obo/NCIT_C62193) (Salivary Gland Mucinous Adenocarcinoma), [NCIT:C62192](http://purl.obolibrary.org/obo/NCIT_C62192) (Salivary Gland Low Grade Cribriform Cystadenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 38.48%


